United States Spine Osteoarthritis Pain Medicine Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Spine Osteoarthritis Pain Medicine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Spine Osteoarthritis Pain Medicine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Spine Osteoarthritis Pain Medicine Overall Market Size
2.1 United States Spine Osteoarthritis Pain Medicine Market Size: 2021 VS 2027
2.2 United States Spine Osteoarthritis Pain Medicine Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Spine Osteoarthritis Pain Medicine Sales: 2016-2027
3 Company Landscape
3.1 Top Spine Osteoarthritis Pain Medicine Players in United States Market
3.2 Top United States Spine Osteoarthritis Pain Medicine Companies Ranked by Revenue
3.3 United States Spine Osteoarthritis Pain Medicine Revenue by Companies
3.4 United States Spine Osteoarthritis Pain Medicine Sales by Companies
3.5 United States Spine Osteoarthritis Pain Medicine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Spine Osteoarthritis Pain Medicine Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Spine Osteoarthritis Pain Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Spine Osteoarthritis Pain Medicine Players in United States Market
3.8.1 List of Tier 1 Spine Osteoarthritis Pain Medicine Companies in United States
3.8.2 List of Tier 2 and Tier 3 Spine Osteoarthritis Pain Medicine Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Spine Osteoarthritis Pain Medicine Market Size Markets, 2021 & 2027
4.1.2 Oral
4.1.3 Injection
4.1.4 External
4.2 By Type - United States Spine Osteoarthritis Pain Medicine Revenue & Forecasts
4.2.1 By Type - United States Spine Osteoarthritis Pain Medicine Revenue, 2016-2021
4.2.2 By Type - United States Spine Osteoarthritis Pain Medicine Revenue, 2022-2027
4.2.3 By Type - United States Spine Osteoarthritis Pain Medicine Revenue Market Share, 2016-2027
4.3 By Type - United States Spine Osteoarthritis Pain Medicine Sales & Forecasts
4.3.1 By Type - United States Spine Osteoarthritis Pain Medicine Sales, 2016-2021
4.3.2 By Type - United States Spine Osteoarthritis Pain Medicine Sales, 2022-2027
4.3.3 By Type - United States Spine Osteoarthritis Pain Medicine Sales Market Share, 2016-2027
4.4 By Type - United States Spine Osteoarthritis Pain Medicine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Spine Osteoarthritis Pain Medicine Market Size, 2021 & 2027
5.1.2 Medical Care
5.1.3 Personal Care
5.2 By Application - United States Spine Osteoarthritis Pain Medicine Revenue & Forecasts
5.2.1 By Application - United States Spine Osteoarthritis Pain Medicine Revenue, 2016-2021
5.2.2 By Application - United States Spine Osteoarthritis Pain Medicine Revenue, 2022-2027
5.2.3 By Application - United States Spine Osteoarthritis Pain Medicine Revenue Market Share, 2016-2027
5.3 By Application - United States Spine Osteoarthritis Pain Medicine Sales & Forecasts
5.3.1 By Application - United States Spine Osteoarthritis Pain Medicine Sales, 2016-2021
5.3.2 By Application - United States Spine Osteoarthritis Pain Medicine Sales, 2022-2027
5.3.3 By Application - United States Spine Osteoarthritis Pain Medicine Sales Market Share, 2016-2027
5.4 By Application - United States Spine Osteoarthritis Pain Medicine Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Overview
6.1.3 Pfizer Spine Osteoarthritis Pain Medicine Sales and Revenue in United States Market (2016-2021)
6.1.4 Pfizer Spine Osteoarthritis Pain Medicine Product Description
6.1.5 Pfizer Recent Developments
6.2 Johnson and Johnson
6.2.1 Johnson and Johnson Corporation Information
6.2.2 Johnson and Johnson Overview
6.2.3 Johnson and Johnson Spine Osteoarthritis Pain Medicine Sales and Revenue in United States Market (2016-2021)
6.2.4 Johnson and Johnson Spine Osteoarthritis Pain Medicine Product Description
6.2.5 Johnson and Johnson Recent Developments
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Overview
6.3.3 GlaxoSmithKline Spine Osteoarthritis Pain Medicine Sales and Revenue in United States Market (2016-2021)
6.3.4 GlaxoSmithKline Spine Osteoarthritis Pain Medicine Product Description
6.3.5 GlaxoSmithKline Recent Developments
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Overview
6.4.3 Bayer Spine Osteoarthritis Pain Medicine Sales and Revenue in United States Market (2016-2021)
6.4.4 Bayer Spine Osteoarthritis Pain Medicine Product Description
6.4.5 Bayer Recent Developments
6.5 Eli Lilly
6.5.1 Eli Lilly Corporation Information
6.5.2 Eli Lilly Overview
6.5.3 Eli Lilly Spine Osteoarthritis Pain Medicine Sales and Revenue in United States Market (2016-2021)
6.5.4 Eli Lilly Spine Osteoarthritis Pain Medicine Product Description
6.5.5 Eli Lilly Recent Developments
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Overview
6.6.3 Novartis Spine Osteoarthritis Pain Medicine Sales and Revenue in United States Market (2016-2021)
6.6.4 Novartis Spine Osteoarthritis Pain Medicine Product Description
6.6.5 Novartis Recent Developments
6.7 Sanofi
6.7.1 Sanofi Corporation Information
6.7.2 Sanofi Overview
6.7.3 Sanofi Spine Osteoarthritis Pain Medicine Sales and Revenue in United States Market (2016-2021)
6.7.4 Sanofi Spine Osteoarthritis Pain Medicine Product Description
6.7.5 Sanofi Recent Developments
6.8 Horizon Pharma
6.8.1 Horizon Pharma Corporation Information
6.8.2 Horizon Pharma Overview
6.8.3 Horizon Pharma Spine Osteoarthritis Pain Medicine Sales and Revenue in United States Market (2016-2021)
6.8.4 Horizon Pharma Spine Osteoarthritis Pain Medicine Product Description
6.8.5 Horizon Pharma Recent Developments
6.9 Abbott
6.9.1 Abbott Corporation Information
6.9.2 Abbott Overview
6.9.3 Abbott Spine Osteoarthritis Pain Medicine Sales and Revenue in United States Market (2016-2021)
6.9.4 Abbott Spine Osteoarthritis Pain Medicine Product Description
6.9.5 Abbott Recent Developments
6.10 Mylan
6.10.1 Mylan Corporation Information
6.10.2 Mylan Overview
6.10.3 Mylan Spine Osteoarthritis Pain Medicine Sales and Revenue in United States Market (2016-2021)
6.10.4 Mylan Spine Osteoarthritis Pain Medicine Product Description
6.10.5 Mylan Recent Developments
6.11 Daiichi Sankyo
6.11.1 Daiichi Sankyo Corporation Information
6.11.2 Daiichi Sankyo Overview
6.11.3 Daiichi Sankyo Spine Osteoarthritis Pain Medicine Sales and Revenue in United States Market (2016-2021)
6.11.4 Daiichi Sankyo Spine Osteoarthritis Pain Medicine Product Description
6.11.5 Daiichi Sankyo Recent Developments
6.12 TEVA
6.12.1 TEVA Corporation Information
6.12.2 TEVA Overview
6.12.3 TEVA Spine Osteoarthritis Pain Medicine Sales and Revenue in United States Market (2016-2021)
6.12.4 TEVA Spine Osteoarthritis Pain Medicine Product Description
6.12.5 TEVA Recent Developments
6.13 Almatica Pharma
6.13.1 Almatica Pharma Corporation Information
6.13.2 Almatica Pharma Overview
6.13.3 Almatica Pharma Spine Osteoarthritis Pain Medicine Sales and Revenue in United States Market (2016-2021)
6.13.4 Almatica Pharma Spine Osteoarthritis Pain Medicine Product Description
6.13.5 Almatica Pharma Recent Developments
6.14 Astellas Pharma
6.14.1 Astellas Pharma Corporation Information
6.14.2 Astellas Pharma Overview
6.14.3 Astellas Pharma Spine Osteoarthritis Pain Medicine Sales and Revenue in United States Market (2016-2021)
6.14.4 Astellas Pharma Spine Osteoarthritis Pain Medicine Product Description
6.14.5 Astellas Pharma Recent Developments
6.15 Tide Pharmaceutical
6.15.1 Tide Pharmaceutical Corporation Information
6.15.2 Tide Pharmaceutical Overview
6.15.3 Tide Pharmaceutical Spine Osteoarthritis Pain Medicine Sales and Revenue in United States Market (2016-2021)
6.15.4 Tide Pharmaceutical Spine Osteoarthritis Pain Medicine Product Description
6.15.5 Tide Pharmaceutical Recent Developments
6.16 Iroko Pharmaceuticals
6.16.1 Iroko Pharmaceuticals Corporation Information
6.16.2 Iroko Pharmaceuticals Overview
6.16.3 Iroko Pharmaceuticals Spine Osteoarthritis Pain Medicine Sales and Revenue in United States Market (2016-2021)
6.16.4 Iroko Pharmaceuticals Spine Osteoarthritis Pain Medicine Product Description
6.16.5 Iroko Pharmaceuticals Recent Developments
6.17 Hengrui Pharmaceutical
6.17.1 Hengrui Pharmaceutical Corporation Information
6.17.2 Hengrui Pharmaceutical Overview
6.17.3 Hengrui Pharmaceutical Spine Osteoarthritis Pain Medicine Sales and Revenue in United States Market (2016-2021)
6.17.4 Hengrui Pharmaceutical Spine Osteoarthritis Pain Medicine Product Description
6.17.5 Hengrui Pharmaceutical Recent Developments
6.18 Abiogen Pharma
6.18.1 Abiogen Pharma Corporation Information
6.18.2 Abiogen Pharma Overview
6.18.3 Abiogen Pharma Spine Osteoarthritis Pain Medicine Sales and Revenue in United States Market (2016-2021)
6.18.4 Abiogen Pharma Spine Osteoarthritis Pain Medicine Product Description
6.18.5 Abiogen Pharma Recent Developments
7 United States Spine Osteoarthritis Pain Medicine Production Capacity, Analysis
7.1 United States Spine Osteoarthritis Pain Medicine Production Capacity, 2016-2027
7.2 Spine Osteoarthritis Pain Medicine Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Spine Osteoarthritis Pain Medicine Supply Chain Analysis
9.1 Spine Osteoarthritis Pain Medicine Industry Value Chain
9.2 Spine Osteoarthritis Pain Medicine Upstream Market
9.3 Spine Osteoarthritis Pain Medicine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Spine Osteoarthritis Pain Medicine Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Spine Osteoarthritis Pain Medicine in United States Market
Table 2. Top Spine Osteoarthritis Pain Medicine Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Spine Osteoarthritis Pain Medicine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Spine Osteoarthritis Pain Medicine Revenue Share by Companies, 2016-2021
Table 5. United States Spine Osteoarthritis Pain Medicine Sales by Companies, (K Units), 2016-2021
Table 6. United States Spine Osteoarthritis Pain Medicine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Spine Osteoarthritis Pain Medicine Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Spine Osteoarthritis Pain Medicine Product Type
Table 9. List of Tier 1 Spine Osteoarthritis Pain Medicine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Spine Osteoarthritis Pain Medicine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Oral
Table 12. Major Manufacturers of Injection
Table 13. By Type - United States Spine Osteoarthritis Pain Medicine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Spine Osteoarthritis Pain Medicine Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Spine Osteoarthritis Pain Medicine Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Spine Osteoarthritis Pain Medicine Sales (K Units), 2016-2021
Table 17. By Type - United States Spine Osteoarthritis Pain Medicine Sales (K Units), 2022-2027
Table 18. By Application - United States Spine Osteoarthritis Pain Medicine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Spine Osteoarthritis Pain Medicine Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Spine Osteoarthritis Pain Medicine Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Spine Osteoarthritis Pain Medicine Sales (K Units), 2016-2021
Table 22. By Application - United States Spine Osteoarthritis Pain Medicine Sales (K Units), 2022-2027
Table 23. Pfizer Corporation Information
Table 24. Pfizer Description and Major Businesses
Table 25. Pfizer Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Pfizer Spine Osteoarthritis Pain Medicine Product
Table 27. Pfizer Recent Developments
Table 28. Johnson and Johnson Corporation Information
Table 29. Johnson and Johnson Description and Major Businesses
Table 30. Johnson and Johnson Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Johnson and Johnson Spine Osteoarthritis Pain Medicine Product
Table 32. Johnson and Johnson Recent Developments
Table 33. GlaxoSmithKline Corporation Information
Table 34. GlaxoSmithKline Description and Major Businesses
Table 35. GlaxoSmithKline Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. GlaxoSmithKline Spine Osteoarthritis Pain Medicine Product
Table 37. GlaxoSmithKline Recent Developments
Table 38. Bayer Corporation Information
Table 39. Bayer Description and Major Businesses
Table 40. Bayer Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Bayer Spine Osteoarthritis Pain Medicine Product
Table 42. Bayer Recent Developments
Table 43. Eli Lilly Corporation Information
Table 44. Eli Lilly Description and Major Businesses
Table 45. Eli Lilly Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Eli Lilly Spine Osteoarthritis Pain Medicine Product
Table 47. Eli Lilly Recent Developments
Table 48. Novartis Corporation Information
Table 49. Novartis Description and Major Businesses
Table 50. Novartis Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Novartis Spine Osteoarthritis Pain Medicine Product
Table 52. Novartis Recent Developments
Table 53. Sanofi Corporation Information
Table 54. Sanofi Description and Major Businesses
Table 55. Sanofi Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Sanofi Spine Osteoarthritis Pain Medicine Product
Table 57. Sanofi Recent Developments
Table 58. Horizon Pharma Corporation Information
Table 59. Horizon Pharma Description and Major Businesses
Table 60. Horizon Pharma Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. Horizon Pharma Spine Osteoarthritis Pain Medicine Product
Table 62. Horizon Pharma Recent Developments
Table 63. Abbott Corporation Information
Table 64. Abbott Description and Major Businesses
Table 65. Abbott Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. Abbott Spine Osteoarthritis Pain Medicine Product
Table 67. Abbott Recent Developments
Table 68. Mylan Corporation Information
Table 69. Mylan Description and Major Businesses
Table 70. Mylan Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 71. Mylan Spine Osteoarthritis Pain Medicine Product
Table 72. Mylan Recent Developments
Table 73. Daiichi Sankyo Corporation Information
Table 74. Daiichi Sankyo Description and Major Businesses
Table 75. Daiichi Sankyo Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 76. Daiichi Sankyo Spine Osteoarthritis Pain Medicine Product
Table 77. Daiichi Sankyo Recent Developments
Table 78. TEVA Corporation Information
Table 79. TEVA Description and Major Businesses
Table 80. TEVA Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 81. TEVA Spine Osteoarthritis Pain Medicine Product
Table 82. TEVA Recent Developments
Table 83. Almatica Pharma Corporation Information
Table 84. Almatica Pharma Description and Major Businesses
Table 85. Almatica Pharma Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 86. Almatica Pharma Spine Osteoarthritis Pain Medicine Product
Table 87. Almatica Pharma Recent Developments
Table 88. Astellas Pharma Corporation Information
Table 89. Astellas Pharma Description and Major Businesses
Table 90. Astellas Pharma Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 91. Astellas Pharma Spine Osteoarthritis Pain Medicine Product
Table 92. Astellas Pharma Recent Developments
Table 93. Tide Pharmaceutical Corporation Information
Table 94. Tide Pharmaceutical Description and Major Businesses
Table 95. Tide Pharmaceutical Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 96. Tide Pharmaceutical Spine Osteoarthritis Pain Medicine Product
Table 97. Tide Pharmaceutical Recent Developments
Table 98. Iroko Pharmaceuticals Corporation Information
Table 99. Iroko Pharmaceuticals Description and Major Businesses
Table 100. Iroko Pharmaceuticals Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 101. Iroko Pharmaceuticals Spine Osteoarthritis Pain Medicine Product
Table 102. Iroko Pharmaceuticals Recent Developments
Table 103. Hengrui Pharmaceutical Corporation Information
Table 104. Hengrui Pharmaceutical Description and Major Businesses
Table 105. Hengrui Pharmaceutical Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 106. Hengrui Pharmaceutical Spine Osteoarthritis Pain Medicine Product
Table 107. Hengrui Pharmaceutical Recent Developments
Table 108. Abiogen Pharma Corporation Information
Table 109. Abiogen Pharma Description and Major Businesses
Table 110. Abiogen Pharma Spine Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 111. Abiogen Pharma Spine Osteoarthritis Pain Medicine Product
Table 112. Abiogen Pharma Recent Developments
Table 113. Spine Osteoarthritis Pain Medicine Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 114. United States Spine Osteoarthritis Pain Medicine Capacity Market Share of Key Manufacturers, 2019-2021
Table 115. Spine Osteoarthritis Pain Medicine Market Opportunities & Trends in United States Market
Table 116. Spine Osteoarthritis Pain Medicine Market Drivers in United States Market
Table 117. Spine Osteoarthritis Pain Medicine Market Restraints in United States Market
Table 118. Spine Osteoarthritis Pain Medicine Raw Materials
Table 119. Spine Osteoarthritis Pain Medicine Raw Materials Suppliers in United States Market
Table 120. Typical Spine Osteoarthritis Pain Medicine Downstream
Table 121. Spine Osteoarthritis Pain Medicine Downstream Clients in United States Market
Table 122. Spine Osteoarthritis Pain Medicine Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Spine Osteoarthritis Pain Medicine Product Picture
Figure 2. Spine Osteoarthritis Pain Medicine Segment by Type
Figure 3. Spine Osteoarthritis Pain Medicine Segment by Application
Figure 4. United States Spine Osteoarthritis Pain Medicine Market Overview: 2020
Figure 5. United States Spine Osteoarthritis Pain Medicine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Spine Osteoarthritis Pain Medicine Revenue, 2016-2027 (US$, Mn)
Figure 7. Spine Osteoarthritis Pain Medicine Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Spine Osteoarthritis Pain Medicine Revenue in 2020
Figure 9. Oral Product Picture
Figure 10. Injection Product Picture
Figure 11. External Product Picture
Figure 12. By Type - United States Spine Osteoarthritis Pain Medicine Sales Market Share, 2016-2027
Figure 13. By Type - United States Spine Osteoarthritis Pain Medicine Revenue Market Share, 2016-2027
Figure 14. By Type - United States Spine Osteoarthritis Pain Medicine Price (USD/Unit), 2016-2027
Figure 15. Medical Care
Figure 16. Personal Care
Figure 17. By Application - United States Spine Osteoarthritis Pain Medicine Sales Market Share, 2016-2027
Figure 18. By Application - United States Spine Osteoarthritis Pain Medicine Revenue Market Share, 2016-2027
Figure 19. By Application - United States Spine Osteoarthritis Pain Medicine Price (USD/Unit), 2016-2027
Figure 20. Pfizer Spine Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Johnson and Johnson Spine Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. GlaxoSmithKline Spine Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Bayer Spine Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Eli Lilly Spine Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Novartis Spine Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Sanofi Spine Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Horizon Pharma Spine Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Abbott Spine Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Mylan Spine Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Daiichi Sankyo Spine Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. TEVA Spine Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Almatica Pharma Spine Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Astellas Pharma Spine Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Tide Pharmaceutical Spine Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Iroko Pharmaceuticals Spine Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Hengrui Pharmaceutical Spine Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Abiogen Pharma Spine Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. United States Spine Osteoarthritis Pain Medicine Production Capacity (K Units), 2016-2027
Figure 39. Spine Osteoarthritis Pain Medicine Industry Value Chain
Figure 40. Marketing Channels